Papers

5

Total Citations

17

H-Index

3

About

Ryosuke Suzuki is a urologic surgeon and researcher whose work centers on refining robotic surgical techniques for prostate and kidney cancers, with a particular focus on improving patient safety and outcomes. His most cited study (7 citations, 2024) investigates the bleeding risks of thienopyridine-class antiplatelet agents during robot-assisted radical prostatectomy, providing critical data for perioperative management. Suzuki has also advanced nephron-sparing surgery through his pioneering work on off-clamp, non-renorrhaphy robot-assisted partial nephrectomy (RAPN), demonstrating that this approach can be safely performed in select patients. His case report on a rare arteriovenous fistula following robot-assisted prostatectomy (2019) highlights his commitment to documenting and understanding uncommon complications. Most recently, Suzuki is exploring the use of 5-aminolevulinic acid-induced fluorescence to differentiate tumor from normal tissue during RAPN for renal cell carcinoma, a promising technique that could improve surgical precision. With additional contributions on atypical oncologic failures after radical cystectomy, Suzuki’s research consistently addresses practical challenges in minimally invasive urologic oncology, making his work valuable for surgeons seeking to optimize robotic procedures and reduce complications.

Research Focus

Key Achievements

3
H-Index
5
Papers
17
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 50
🏛 Institutions: Numazu City Hospital, Kobe City Medical Center General Hospital, Kyoto University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago